Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder

Autor: Minna M. Kanervo, Sarimari J. Tupola, Eeva M. Nikkola, Krista M. Rantakari, Hanna K. Kahila

Publikováno v: Acta Obstetricia et Gynecologica Scandinavica. 102:313-322

IntroductionCurrent WHO guidelines recommend using methadone or buprenorphine as maintenance treatments for maternal opioid use disorder. However, buprenorphine-naloxone, with a lower abuse risk than buprenorphine monotherapy or methadone, offers a p

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9133f34c1d1dc9f62d896d1160edfb
https://doi.org/10.1111/aogs.14497

Extended-release versus oral buprenorphine as opioid maintenance treatment during pregnancy-maternal and neonatal outcomes.

Autor: Kanervo M; University of Helsinki Doctoral School, P.O. box 4, FI-00014 Helsinki, Finland; Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital and University of Helsinki, P.O. box 347, FI-00029 HUS, Helsinki, Finland. Electronic address: minna.kanervo@hus.fi., Tupola S; Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital and University of Helsinki, P.O. box 347, FI-00029 HUS, Helsinki, Finland., Nikkola E; Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital and University of Helsinki, P.O. box 347, FI-00029 HUS, Helsinki, Finland., Rantakari K; Children's Hospital, Pediatric Research Center, HUS Helsinki University Hospital and University of Helsinki, P.O. box 347, FI-00029 HUS, Helsinki, Finland., Kahila H; Gynecology and Obstetrics, HUS Helsinki University Hospital and University of Helsinki, P.O. box 140, FI-00029 HUS, Helsinki, Finland.

Publikováno v: European journal of obstetrics, gynecology, and reproductive biology [Eur J Obstet Gynecol Reprod Biol] 2024 Jun; Vol. 297, pp. 106-110. Date of Electronic Publication: 2024 Apr 07.